Lang James Paul's Form 4 filing
OptimizeRx Corp (OPRX) · filed Mar 19, 2025
- Accession no.
- 0001628280-25-013918
- Filed
- Mar 19, 2025
- Trade date
- Mar 14, 2025
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.44M. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lang James PaulCIK 0001703090 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Common Stock | PPurchaseAcquired | +321,408 | $7.60 | +$2,442,700.8 | 389,452 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.